Visual System Vulnerability In Dementia: From Detection To Determinants
About the Research Project
Program
Award Type
Standard
Award Amount
$291,739.19
Active Dates
July 01, 2026 - June 30, 2029
Grant ID
A2026032S
Co-Principal Investigator(s)
David Cash, PhD, University College London Institute of Neurology
Andre Altmann, PhD, University College London
Goals
This project aims to compare genetic factors associated with vulnerability of the brain’s visual networks with forms of Alzheimer’s disease characterized by predominant visual loss.
Summary
Cortical visual (‘brainsight’ not eyesight loss) is the earliest sign of dementia for people with posterior cortical atrophy, in whom vulnerability of the brain’s visual rather than memory system causes ‘visual-led Alzheimer’s disease’.
We will use a novel brainsight test and brain scans from 35,000 volunteers in a national ageing study (UK Biobank) to improve detection of visual system vulnerability.
We will compare genetic risk factors associated with visual system vulnerability and visual-led Alzheimer’s disease to determine why Alzheimer’s disease may affect people in different ways.
Unique and Innovative
People with ‘brainsight’ loss are often misdiagnosed as having eye conditions. We will use a novel test to detect and distinguish dementia-related ‘brainsight’ from eyesight loss.
Understanding risks for visual-led Alzheimer’s disease (AD) has been limited by diagnostic challenges and small sample sizes. We will compare genetic factors associated with visual system vulnerability in the largest neuroimaging study worldwide with the largest genetic studies of visual-led forms of AD.
Foreseeable Benefits
• Improved detection of brainsight loss across research and clinical settings.
• Understanding why Alzheimer’s disease may particularly attack the brain’s visual rather than memory system.
• Informing future research to identify treatments better tailored to the type of Alzheimer’s disease one is affected by.
Related Grants
Alzheimer's Disease Research
Determining the Cellular Impacts of ABCA7 Mutations in Alzheimer’s Disease
Active Dates
July 01, 2025 - June 30, 2027
Principal Investigator
Sarah Heuer, PhD
Current Organization
Brigham and Women's Hospital
Determining the Cellular Impacts of ABCA7 Mutations in Alzheimer’s Disease
Active Dates
July 01, 2025 - June 30, 2027
Principal Investigator
Sarah Heuer, PhD
Current Organization
Brigham and Women's Hospital
Alzheimer's Disease Research
A New Look at Genetics Using Old Data: Alzheimer's Progression
Active Dates
July 01, 2025 - June 30, 2028
Principal Investigator
John Hardy, PhD, FRS
Current Organization
University College London
A New Look at Genetics Using Old Data: Alzheimer's Progression
Active Dates
July 01, 2025 - June 30, 2028
Principal Investigator
John Hardy, PhD, FRS
Current Organization
University College London
Alzheimer's Disease Research
PLCG2 Variants and Their Implications in Alzheimer's Disease
Active Dates
July 01, 2025 - June 30, 2028
Principal Investigator
Hongjun Fu, PhD
Current Organization
The Ohio State University
PLCG2 Variants and Their Implications in Alzheimer's Disease
Active Dates
July 01, 2025 - June 30, 2028
Principal Investigator
Hongjun Fu, PhD
Current Organization
The Ohio State University